Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Study Identifier
MAF/AGN/OPH/RET/007
CT.gov Identifier
NCT01568021
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Macular Edema * Prescribed OZURDEX®
    Exclusion Criteria:
    * None

    Protocol Summary

    This multicenter observational study will assess the efficacy and tolerability of OZURDEX® in clinical practice, and will assess the time at which patients are considered for retreatment.

    Study Locations

    Location
    Status
    Location
    Glostrup Municipality, Denmark
    Status
    Not applicable
    Location
    Oslo, Norway
    Status
    Not applicable
    Location
    Uppsala, Sweden
    Status
    Not applicable